Biocept, Inc. announced the appointment of Samuel D. Riccitelli to its Board of Directors, effective immediately. Mr. Riccitelli is joining the Board ahead of the planned retirement of Bruce A. Huebner, who will retire from the Biocept Board of Directors on November 30, 2020. Mr. Riccitelli brings to Biocept extensive experience in the molecular diagnostics industry, having served in executive-level positions and on the Boards of multiple publicly traded companies. At Biocept, he will initially serve on the Audit Committee and the Science and Technology Committee. Mr. Riccitelli has been in the healthcare industry for more than 35 years. He currently serves as an independent consultant to healthcare companies and is a Director of OrthoPediatrics Corp., a company focused on the orthopedic implant needs of children. He previously was Chief Executive Officer of Pathnostics, LLC.